# Quantum Computing Inc.: financial statements, quarterly

QUBT · Nasdaq · CIK 1758009 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qubt.md) · [Financials](/companies/qubt/financials.md) · [Filings](/companies/qubt/filings.md) · [Insiders](/companies/qubt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qubt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.1](/filings/0001213900-24-094983.md) | [0.1 d](/filings/0001213900-26-022417.md) | [0.0](/filings/0001213900-25-044341.md) | [0.2](/filings/0001213900-25-076846.md) | [0.1](/filings/0001213900-25-110814.md) | [0.1 d](/filings/0001213900-26-022417.md) | [0.0](/filings/0001213900-26-054473.md) | [0.1](/filings/0001628280-26-055218.md) | [0.4](/filings/0001213900-25-110814.md) | [0.2 d](/filings/0001213900-26-022417.md) | [3.7](/filings/0001213900-26-054473.md) | [5.6](/filings/0001628280-26-055218.md) |
| Cost of revenue | $m | [0.0](/filings/0001213900-24-094983.md) | [0.1 d](/filings/0001213900-26-022417.md) | [0.0](/filings/0001213900-25-044341.md) | [0.1](/filings/0001213900-25-076846.md) | [0.1](/filings/0001213900-25-110814.md) | [0.0 d](/filings/0001213900-26-022417.md) | [0.0](/filings/0001213900-26-054473.md) | [0.0](/filings/0001628280-26-055218.md) | [0.3](/filings/0001213900-25-110814.md) | [0.3 d](/filings/0001213900-26-022417.md) | [4.4](/filings/0001213900-26-054473.md) | [6.7](/filings/0001628280-26-055218.md) |
| Gross profit | $m | [0.0](/filings/0001213900-24-094983.md) | [0.0 d](/filings/0001213900-26-022417.md) | [0.0](/filings/0001213900-25-044341.md) | [0.1](/filings/0001213900-25-076846.md) | [0.0](/filings/0001213900-25-110814.md) | [0.0 d](/filings/0001213900-26-022417.md) | [0.0](/filings/0001213900-26-054473.md) | [0.0](/filings/0001628280-26-055218.md) | [0.1](/filings/0001213900-25-110814.md) | [(0.1) d](/filings/0001213900-26-022417.md) | [(0.7)](/filings/0001213900-26-054473.md) | [(1.2)](/filings/0001628280-26-055218.md) |
| Research and development | $m | [2.3](/filings/0001213900-24-094983.md) | [1.9 d](/filings/0001213900-26-022417.md) | [2.2](/filings/0001213900-25-044341.md) | [2.1](/filings/0001213900-25-076846.md) | [2.2](/filings/0001213900-25-110814.md) | [4.8 d](/filings/0001213900-26-022417.md) | [3.0](/filings/0001213900-26-054473.md) | [6.0](/filings/0001628280-26-055218.md) | [4.5](/filings/0001213900-25-110814.md) | [7.0 d](/filings/0001213900-26-022417.md) | [7.0](/filings/0001213900-26-054473.md) | [8.4](/filings/0001628280-26-055218.md) |
| Selling, general and administrative | $m | [3.7](/filings/0001213900-24-094983.md) | [4.3 d](/filings/0001213900-24-077754.md) | [3.7](/filings/0001213900-24-084716.md) | [2.8](/filings/0001213900-24-084727.md) | [2.8](/filings/0001213900-24-094983.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(6.6)](/filings/0001213900-24-094983.md) | [(6.6) d](/filings/0001213900-26-022417.md) | [(6.3)](/filings/0001213900-25-044341.md) | [(5.3)](/filings/0001213900-25-076846.md) | [(5.4)](/filings/0001213900-25-110814.md) | [(8.9) d](/filings/0001213900-26-022417.md) | [(8.3)](/filings/0001213900-26-054473.md) | [(10.2)](/filings/0001628280-26-055218.md) | [(10.4)](/filings/0001213900-25-110814.md) | [(22.2) d](/filings/0001213900-26-022417.md) | [(20.6)](/filings/0001213900-26-054473.md) | [(23.0)](/filings/0001628280-26-055218.md) |
| Interest expense | $m | not reported | not reported | [0.2](/filings/0001213900-25-044341.md) | [0.0 d](/filings/0001213900-25-076846.md) | [0.3](/filings/0001213900-25-110814.md) | [2.0 d](/filings/0001213900-26-022417.md) | [0.1](/filings/0001213900-26-054473.md) | [0.1](/filings/0001628280-26-055218.md) | [0.0](/filings/0001213900-25-110814.md) | [(0.1) d](/filings/0001213900-26-022417.md) | [0.2](/filings/0001213900-26-054473.md) | [0.0](/filings/0001628280-26-055218.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-055218.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-26-055218.md) |
| Net income | $m | [(6.8)](/filings/0001213900-24-094983.md) | [(6.6) d](/filings/0001213900-26-022417.md) | [(6.4)](/filings/0001213900-25-044341.md) | [(5.2)](/filings/0001213900-25-076846.md) | [(5.7)](/filings/0001213900-25-110814.md) | [(51.2) d](/filings/0001213900-26-022417.md) | [17.0](/filings/0001213900-26-054473.md) | [(36.5)](/filings/0001628280-26-055218.md) | [2.4](/filings/0001213900-25-110814.md) | [(1.6) d](/filings/0001213900-26-022417.md) | [(4.1)](/filings/0001213900-26-054473.md) | [(11.8)](/filings/0001628280-26-055218.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001213900-24-094983.md) | not reported | [(0.08)](/filings/0001213900-25-044341.md) | [(0.06)](/filings/0001213900-25-076846.md) | [(0.06)](/filings/0001213900-25-110814.md) | not reported | [0.11](/filings/0001213900-26-054473.md) | [(0.26)](/filings/0001628280-26-055218.md) | [0.01](/filings/0001213900-25-110814.md) | not reported | [(0.02)](/filings/0001213900-26-054473.md) | [(0.05)](/filings/0001628280-26-055218.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001213900-24-094983.md) | not reported | [(0.08)](/filings/0001213900-25-044341.md) | [(0.06)](/filings/0001213900-25-076846.md) | [(0.06)](/filings/0001213900-25-110814.md) | not reported | [0.13](/filings/0001213900-26-054473.md) | [(0.26)](/filings/0001628280-26-055218.md) | [0.01](/filings/0001213900-25-110814.md) | not reported | [(0.02)](/filings/0001213900-26-054473.md) | [(0.05)](/filings/0001628280-26-055218.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.4](/filings/0001213900-23-086246.md) | [2.1](/filings/0001213900-25-025561.md) | [6.1](/filings/0001213900-24-084716.md) | [2.5](/filings/0001213900-24-084727.md) | [3.1](/filings/0001213900-24-094983.md) | [78.9](/filings/0001213900-26-022417.md) | [166](/filings/0001213900-25-044341.md) | [349](/filings/0001213900-25-076846.md) | [352](/filings/0001213900-25-110814.md) | [738](/filings/0001628280-26-055218.md) | [258](/filings/0001213900-26-054473.md) | [189](/filings/0001628280-26-055218.md) |
| Current assets | $m | [8.1](/filings/0001213900-23-086246.md) | [2.7](/filings/0001213900-25-025561.md) | [6.8](/filings/0001213900-24-084716.md) | [3.4](/filings/0001213900-24-084727.md) | [3.9](/filings/0001213900-24-094983.md) | [79.2](/filings/0001213900-26-022417.md) | [167](/filings/0001213900-25-044341.md) | [350](/filings/0001213900-25-076846.md) | [563](/filings/0001213900-25-110814.md) | [1,134](/filings/0001628280-26-055218.md) | [1,005](/filings/0001213900-26-054473.md) | [988](/filings/0001628280-26-055218.md) |
| Total assets | $m | [89.3](/filings/0001213900-23-086246.md) | [74.4](/filings/0001213900-25-025561.md) | [79.2](/filings/0001213900-24-084716.md) | [76.0](/filings/0001213900-24-084727.md) | [76.8](/filings/0001213900-24-094983.md) | [154](/filings/0001213900-26-022417.md) | [243](/filings/0001213900-25-044341.md) | [426](/filings/0001213900-25-076846.md) | [898](/filings/0001213900-25-110814.md) | [1,619](/filings/0001628280-26-055218.md) | [1,621](/filings/0001213900-26-054473.md) | [1,639](/filings/0001628280-26-055218.md) |
| Current liabilities | $m | [8.1](/filings/0001213900-23-086246.md) | [4.8](/filings/0001213900-25-025561.md) | [3.1](/filings/0001213900-24-084716.md) | [2.9](/filings/0001213900-24-084727.md) | [2.4](/filings/0001213900-24-094983.md) | [4.6](/filings/0001213900-26-022417.md) | [3.7](/filings/0001213900-25-044341.md) | [4.0](/filings/0001213900-25-076846.md) | [3.6](/filings/0001213900-25-110814.md) | [11.1](/filings/0001628280-26-055218.md) | [15.1](/filings/0001213900-26-054473.md) | [18.6](/filings/0001628280-26-055218.md) |
| Total liabilities | $m | [8.1](/filings/0001213900-23-086246.md) | [5.7](/filings/0001213900-25-025561.md) | [3.9](/filings/0001213900-24-084716.md) | [3.6](/filings/0001213900-24-084727.md) | [10.9](/filings/0001213900-24-094983.md) | [46.3](/filings/0001213900-26-022417.md) | [21.7](/filings/0001213900-25-044341.md) | [30.1](/filings/0001213900-25-076846.md) | [20.3](/filings/0001213900-25-110814.md) | [20.7](/filings/0001628280-26-055218.md) | [23.4](/filings/0001213900-26-054473.md) | [47.2](/filings/0001628280-26-055218.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | [1.9](/filings/0001213900-24-077754.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [72.2](/filings/0001213900-24-094983.md) | [68.7](/filings/0001213900-26-022417.md) | [67.6](/filings/0001213900-25-076846.md) | [65.5](/filings/0001213900-25-110814.md) | [60.4](/filings/0001213900-25-110814.md) | [107](/filings/0001628280-26-055218.md) | [221](/filings/0001628280-26-055218.md) | [396](/filings/0001628280-26-055218.md) | [878](/filings/0001213900-25-110814.md) | [1,598](/filings/0001628280-26-055218.md) | [1,597](/filings/0001628280-26-055218.md) | [1,592](/filings/0001628280-26-055218.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.4) d](/filings/0001213900-24-094983.md) | [(5.0) d](/filings/0001213900-26-022417.md) | [(3.8)](/filings/0001213900-25-044341.md) | [(4.0) d](/filings/0001213900-25-076846.md) | [(4.6) d](/filings/0001213900-25-110814.md) | [(3.8) d](/filings/0001213900-26-022417.md) | [(4.4)](/filings/0001213900-26-054473.md) | [(6.1) d](/filings/0001628280-26-055218.md) | [(8.7) d](/filings/0001213900-25-110814.md) | [(11.0) d](/filings/0001213900-26-022417.md) | [(9.4)](/filings/0001213900-26-054473.md) | [(13.9) d](/filings/0001628280-26-055218.md) |
| Capital expenditure | $m | [1.6 d](/filings/0001213900-24-094983.md) | [(0.1) d](/filings/0001213900-26-022417.md) | [1.6](/filings/0001213900-25-044341.md) | [1.1 d](/filings/0001213900-25-076846.md) | [0.5 d](/filings/0001213900-25-110814.md) | [2.9 d](/filings/0001213900-26-022417.md) | [1.7](/filings/0001213900-26-054473.md) | [1.0 d](/filings/0001628280-26-055218.md) | [2.8 d](/filings/0001213900-25-110814.md) | [1.2 d](/filings/0001213900-26-022417.md) | [1.8](/filings/0001213900-26-054473.md) | [2.7 d](/filings/0001628280-26-055218.md) |
| Dividends paid | $m | [0.2 d](/filings/0001213900-24-094983.md) | [0.2 d](/filings/0001213900-26-022417.md) | [0.2](/filings/0001213900-25-044341.md) | [0.0 d](/filings/0001213900-25-076846.md) | [0.0 d](/filings/0001213900-25-110814.md) | [0.0 d](/filings/0001213900-26-022417.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [68.9](/filings/0001213900-23-086246.md) | [58.9](/filings/0001213900-24-084716.md) | [62.7](/filings/0001213900-24-084727.md) | [71.6](/filings/0001213900-24-094983.md) | [81.9](/filings/0001213900-25-044341.md) | [93.6](/filings/0001213900-25-076846.md) | [93.0](/filings/0001213900-25-110814.md) | [153](/filings/0001213900-26-054473.md) | [141](/filings/0001628280-26-055218.md) | [167](/filings/0001213900-25-110814.md) | [224](/filings/0001213900-26-054473.md) | [225](/filings/0001628280-26-055218.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 226,346,861 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055218.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.